Genetic alterations that were significantly common in ATC included tumor suppression genes (eg, TP53, NF2, and RB1), PI3K/AKT pathway genes, cell cycle pathway genes, and epigenetic modification genes (eg, TET2) (Table 2). The gene discussed is TP53; the disease is neoplasm.